Sun, Dec 28, 2014, 3:24 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • racavalli racavalli Jan 28, 2013 2:37 AM Flag

    Hey racavalli Have a question for you

    My understanding is that the final phase III trial has already been completed and that they are only waiting for the FDA's response. I believe these trials took place in the U.S. recently.

    They are looking U.S. approval and some other foreign countries.

    I think we will hear very soon!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I thought it was funny when you wrote in a previous post "I have done more due diligence on this company then even the analyst at Aegis", especially when you now write "My understanding is that the final phase III trial has already been completed and that they are only waiting for the FDA's response. I believe these trials took place in the U.S. recently."

      Do you understand that all clinical studies in the US as listed on the FDA clin trials dot gov site? Are any of AMPE's studies listed there? Hmmmmm.

      Did you eve read AMPE's June 21 press release, which said "The FDA provided all the necessary guidance on the design and conduct of two concurrent phase III pivotal clinical trials of approximately 15 weeks duration."? Do you think AMPE just snuck those in?

      Also, AMPE stated in the December investor presentation for Zertane "two concurrent
      Phase III pivotal trials set to begin enrollment in 1Q13". Did you miss this?

    • If you listen carefully to the investor presentation they said they are waiting for FDA approval to start Zertane's "pivotal trial". Why makes you think the Phase 3 trial has already been completed?

 
AMPE
3.44+0.010(+0.29%)Dec 26 4:02 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
PG&E Corporation
NYSEFri, Dec 26, 2014 4:02 PM EST
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST